Loading…

Transcriptional response networks for elucidating mechanisms of action of multitargeted agents

•Elucidation of a compound's target mechanisms is key to predicting its phenotypic effects.•Computational network pharmacology models provide hypotheses on multi-target mechanisms.•Data-driven models can lead to unbiased findings and novel drug development paths.•Model predictions reduce the nu...

Full description

Saved in:
Bibliographic Details
Published in:Drug discovery today 2016-07, Vol.21 (7), p.1063-1075
Main Authors: Kibble, Milla, Khan, Suleiman A., Saarinen, Niina, Iorio, Francesco, Saez-Rodriguez, Julio, Mäkelä, Sari, Aittokallio, Tero
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c408t-df9219492a0f7acb6c7e3d1139472760685746c2277a19a0bcec3f3b12fa38b23
cites cdi_FETCH-LOGICAL-c408t-df9219492a0f7acb6c7e3d1139472760685746c2277a19a0bcec3f3b12fa38b23
container_end_page 1075
container_issue 7
container_start_page 1063
container_title Drug discovery today
container_volume 21
creator Kibble, Milla
Khan, Suleiman A.
Saarinen, Niina
Iorio, Francesco
Saez-Rodriguez, Julio
Mäkelä, Sari
Aittokallio, Tero
description •Elucidation of a compound's target mechanisms is key to predicting its phenotypic effects.•Computational network pharmacology models provide hypotheses on multi-target mechanisms.•Data-driven models can lead to unbiased findings and novel drug development paths.•Model predictions reduce the number of in vitro and in vivo target validation experiments.•These models also enable systematic discovery of drug repositioning opportunities. Systems-level drug response phenotypes combined with network models offer an exciting means for elucidating the mechanisms of action of polypharmacological agents, including multitargeted natural products. Drug discovery is moving away from the single target-based approach towards harnessing the potential of polypharmacological agents that modulate the activity of multiple nodes in the complex networks of deregulations underlying disease phenotypes. Computational network pharmacology methods that use systems-level drug–response phenotypes, such as those originating from genome-wide transcriptomic profiles, have proved particularly effective for elucidating the mechanisms of action of multitargeted compounds. Here, we show, via the case study of the natural product pinosylvin, how the combination of two complementary network-based methods can provide novel, unexpected mechanistic insights. This case study also illustrates that elucidating the mechanism of action of multitargeted natural products through transcriptional response-based approaches is a challenging endeavor, often requiring multiple computational–experimental iterations.
doi_str_mv 10.1016/j.drudis.2016.03.001
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1797255581</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1359644616300708</els_id><sourcerecordid>1797255581</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-df9219492a0f7acb6c7e3d1139472760685746c2277a19a0bcec3f3b12fa38b23</originalsourceid><addsrcrecordid>eNp9kEtr3TAQRkVoaB7tPyjFy27s6GFL1qZQQl4QyCbdVsjS-Ea3tnSrkRP67-PLTbvMambgfDPMIeQLow2jTF5sG58XH7Dh69RQ0VDKjsgp61Vfd73gH9ZedLqWbStPyBnidgW47uRHcsKlVrpr1Sn59ZhtRJfDroQU7VRlwF2KCFWE8pLyb6zGlCuYFhe8LSFuqhnck40BZ6zSWFm3D-67eZlKKDZvoICv7AZiwU_keLQTwue3ek5-Xl89Xt7W9w83d5c_7mvX0r7UftSc6VZzS0dl3SCdAuEZE7pVXEkq-0610nGulGXa0sGBE6MYGB-t6Acuzsm3w95dTn8WwGLmgA6myUZICxqmtOJd1_VsRdsD6nJCzDCaXQ6zzX8No2Zv1mzNwazZmzVUmFXcGvv6dmEZZvD_Q_9UrsD3AwDrn88BskEXIDrwIYMrxqfw_oVX3-mNsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1797255581</pqid></control><display><type>article</type><title>Transcriptional response networks for elucidating mechanisms of action of multitargeted agents</title><source>ScienceDirect Journals</source><creator>Kibble, Milla ; Khan, Suleiman A. ; Saarinen, Niina ; Iorio, Francesco ; Saez-Rodriguez, Julio ; Mäkelä, Sari ; Aittokallio, Tero</creator><creatorcontrib>Kibble, Milla ; Khan, Suleiman A. ; Saarinen, Niina ; Iorio, Francesco ; Saez-Rodriguez, Julio ; Mäkelä, Sari ; Aittokallio, Tero</creatorcontrib><description>•Elucidation of a compound's target mechanisms is key to predicting its phenotypic effects.•Computational network pharmacology models provide hypotheses on multi-target mechanisms.•Data-driven models can lead to unbiased findings and novel drug development paths.•Model predictions reduce the number of in vitro and in vivo target validation experiments.•These models also enable systematic discovery of drug repositioning opportunities. Systems-level drug response phenotypes combined with network models offer an exciting means for elucidating the mechanisms of action of polypharmacological agents, including multitargeted natural products. Drug discovery is moving away from the single target-based approach towards harnessing the potential of polypharmacological agents that modulate the activity of multiple nodes in the complex networks of deregulations underlying disease phenotypes. Computational network pharmacology methods that use systems-level drug–response phenotypes, such as those originating from genome-wide transcriptomic profiles, have proved particularly effective for elucidating the mechanisms of action of multitargeted compounds. Here, we show, via the case study of the natural product pinosylvin, how the combination of two complementary network-based methods can provide novel, unexpected mechanistic insights. This case study also illustrates that elucidating the mechanism of action of multitargeted natural products through transcriptional response-based approaches is a challenging endeavor, often requiring multiple computational–experimental iterations.</description><identifier>ISSN: 1359-6446</identifier><identifier>EISSN: 1878-5832</identifier><identifier>DOI: 10.1016/j.drudis.2016.03.001</identifier><identifier>PMID: 26979547</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Computational Biology ; Drug Discovery ; Gene Regulatory Networks ; Humans</subject><ispartof>Drug discovery today, 2016-07, Vol.21 (7), p.1063-1075</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-df9219492a0f7acb6c7e3d1139472760685746c2277a19a0bcec3f3b12fa38b23</citedby><cites>FETCH-LOGICAL-c408t-df9219492a0f7acb6c7e3d1139472760685746c2277a19a0bcec3f3b12fa38b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26979547$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kibble, Milla</creatorcontrib><creatorcontrib>Khan, Suleiman A.</creatorcontrib><creatorcontrib>Saarinen, Niina</creatorcontrib><creatorcontrib>Iorio, Francesco</creatorcontrib><creatorcontrib>Saez-Rodriguez, Julio</creatorcontrib><creatorcontrib>Mäkelä, Sari</creatorcontrib><creatorcontrib>Aittokallio, Tero</creatorcontrib><title>Transcriptional response networks for elucidating mechanisms of action of multitargeted agents</title><title>Drug discovery today</title><addtitle>Drug Discov Today</addtitle><description>•Elucidation of a compound's target mechanisms is key to predicting its phenotypic effects.•Computational network pharmacology models provide hypotheses on multi-target mechanisms.•Data-driven models can lead to unbiased findings and novel drug development paths.•Model predictions reduce the number of in vitro and in vivo target validation experiments.•These models also enable systematic discovery of drug repositioning opportunities. Systems-level drug response phenotypes combined with network models offer an exciting means for elucidating the mechanisms of action of polypharmacological agents, including multitargeted natural products. Drug discovery is moving away from the single target-based approach towards harnessing the potential of polypharmacological agents that modulate the activity of multiple nodes in the complex networks of deregulations underlying disease phenotypes. Computational network pharmacology methods that use systems-level drug–response phenotypes, such as those originating from genome-wide transcriptomic profiles, have proved particularly effective for elucidating the mechanisms of action of multitargeted compounds. Here, we show, via the case study of the natural product pinosylvin, how the combination of two complementary network-based methods can provide novel, unexpected mechanistic insights. This case study also illustrates that elucidating the mechanism of action of multitargeted natural products through transcriptional response-based approaches is a challenging endeavor, often requiring multiple computational–experimental iterations.</description><subject>Animals</subject><subject>Computational Biology</subject><subject>Drug Discovery</subject><subject>Gene Regulatory Networks</subject><subject>Humans</subject><issn>1359-6446</issn><issn>1878-5832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kEtr3TAQRkVoaB7tPyjFy27s6GFL1qZQQl4QyCbdVsjS-Ea3tnSrkRP67-PLTbvMambgfDPMIeQLow2jTF5sG58XH7Dh69RQ0VDKjsgp61Vfd73gH9ZedLqWbStPyBnidgW47uRHcsKlVrpr1Sn59ZhtRJfDroQU7VRlwF2KCFWE8pLyb6zGlCuYFhe8LSFuqhnck40BZ6zSWFm3D-67eZlKKDZvoICv7AZiwU_keLQTwue3ek5-Xl89Xt7W9w83d5c_7mvX0r7UftSc6VZzS0dl3SCdAuEZE7pVXEkq-0610nGulGXa0sGBE6MYGB-t6Acuzsm3w95dTn8WwGLmgA6myUZICxqmtOJd1_VsRdsD6nJCzDCaXQ6zzX8No2Zv1mzNwazZmzVUmFXcGvv6dmEZZvD_Q_9UrsD3AwDrn88BskEXIDrwIYMrxqfw_oVX3-mNsg</recordid><startdate>201607</startdate><enddate>201607</enddate><creator>Kibble, Milla</creator><creator>Khan, Suleiman A.</creator><creator>Saarinen, Niina</creator><creator>Iorio, Francesco</creator><creator>Saez-Rodriguez, Julio</creator><creator>Mäkelä, Sari</creator><creator>Aittokallio, Tero</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201607</creationdate><title>Transcriptional response networks for elucidating mechanisms of action of multitargeted agents</title><author>Kibble, Milla ; Khan, Suleiman A. ; Saarinen, Niina ; Iorio, Francesco ; Saez-Rodriguez, Julio ; Mäkelä, Sari ; Aittokallio, Tero</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-df9219492a0f7acb6c7e3d1139472760685746c2277a19a0bcec3f3b12fa38b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Computational Biology</topic><topic>Drug Discovery</topic><topic>Gene Regulatory Networks</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kibble, Milla</creatorcontrib><creatorcontrib>Khan, Suleiman A.</creatorcontrib><creatorcontrib>Saarinen, Niina</creatorcontrib><creatorcontrib>Iorio, Francesco</creatorcontrib><creatorcontrib>Saez-Rodriguez, Julio</creatorcontrib><creatorcontrib>Mäkelä, Sari</creatorcontrib><creatorcontrib>Aittokallio, Tero</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug discovery today</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kibble, Milla</au><au>Khan, Suleiman A.</au><au>Saarinen, Niina</au><au>Iorio, Francesco</au><au>Saez-Rodriguez, Julio</au><au>Mäkelä, Sari</au><au>Aittokallio, Tero</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcriptional response networks for elucidating mechanisms of action of multitargeted agents</atitle><jtitle>Drug discovery today</jtitle><addtitle>Drug Discov Today</addtitle><date>2016-07</date><risdate>2016</risdate><volume>21</volume><issue>7</issue><spage>1063</spage><epage>1075</epage><pages>1063-1075</pages><issn>1359-6446</issn><eissn>1878-5832</eissn><abstract>•Elucidation of a compound's target mechanisms is key to predicting its phenotypic effects.•Computational network pharmacology models provide hypotheses on multi-target mechanisms.•Data-driven models can lead to unbiased findings and novel drug development paths.•Model predictions reduce the number of in vitro and in vivo target validation experiments.•These models also enable systematic discovery of drug repositioning opportunities. Systems-level drug response phenotypes combined with network models offer an exciting means for elucidating the mechanisms of action of polypharmacological agents, including multitargeted natural products. Drug discovery is moving away from the single target-based approach towards harnessing the potential of polypharmacological agents that modulate the activity of multiple nodes in the complex networks of deregulations underlying disease phenotypes. Computational network pharmacology methods that use systems-level drug–response phenotypes, such as those originating from genome-wide transcriptomic profiles, have proved particularly effective for elucidating the mechanisms of action of multitargeted compounds. Here, we show, via the case study of the natural product pinosylvin, how the combination of two complementary network-based methods can provide novel, unexpected mechanistic insights. This case study also illustrates that elucidating the mechanism of action of multitargeted natural products through transcriptional response-based approaches is a challenging endeavor, often requiring multiple computational–experimental iterations.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>26979547</pmid><doi>10.1016/j.drudis.2016.03.001</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1359-6446
ispartof Drug discovery today, 2016-07, Vol.21 (7), p.1063-1075
issn 1359-6446
1878-5832
language eng
recordid cdi_proquest_miscellaneous_1797255581
source ScienceDirect Journals
subjects Animals
Computational Biology
Drug Discovery
Gene Regulatory Networks
Humans
title Transcriptional response networks for elucidating mechanisms of action of multitargeted agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T23%3A08%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcriptional%20response%20networks%20for%20elucidating%20mechanisms%20of%20action%20of%20multitargeted%20agents&rft.jtitle=Drug%20discovery%20today&rft.au=Kibble,%20Milla&rft.date=2016-07&rft.volume=21&rft.issue=7&rft.spage=1063&rft.epage=1075&rft.pages=1063-1075&rft.issn=1359-6446&rft.eissn=1878-5832&rft_id=info:doi/10.1016/j.drudis.2016.03.001&rft_dat=%3Cproquest_cross%3E1797255581%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-df9219492a0f7acb6c7e3d1139472760685746c2277a19a0bcec3f3b12fa38b23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1797255581&rft_id=info:pmid/26979547&rfr_iscdi=true